The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome

发表于 2026-8-19 22:36:58

本帖最后由 guangaiturang 于 2026-8-20 07:35 编辑

期刊：The Journal of Clinical Pharmacology

文献作者：Simona Dinicola; Tony T. Y. Chiu; Vittorio Unfer; Gianfranco Carlomagno; Mariano Bizzarri

出版日期：2014-10-

DOI号：10.1002/jcph.362

下载链接：https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/JCPH.362

文献链接：https://doi.org/10.1002/jcph.362

当前文献来源于 Wiley。

备注信息：

发表于 2026-8-20 08:46:11

: 当前求助处于待确认状态,请尽快下载
如果48小时后该求助仍未采纳，系统将自动采纳。

[Wiley] The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Wiley] The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome 一键复制

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Wiley] The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome